GL1X · GenesisL1 explorer

MolNFT v1 · #54397 · protein

2XNF: The mediator MED25 activator interaction domain: structure and cooperative binding of VP16 subdomains

2XNF · Mediator of RNA polymerase II transcription subunit 25: “The mediator MED25 activator interaction domain: structure and cooperative binding of VP16 subdomains”. Solution nmr, 2 pockets (best druggability 0.36). MolNFT v1 #54397 on…

3D structure of 2XNF: The mediator MED25 activator interaction domain: structure and cooperative binding of VP16 subdomains (MolNFT v1 / PDB)
3D structure of 2XNF: The mediator MED25 activator interaction domain: structure and cooperative binding of VP16 subdomains (MolNFT v1 / PDB)
PDB
2XNF
Type
protein
Length
159 residues
Chains
1
Method
solution nmr
Deposited
02-AUG-10
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mediator of RNA polymerase II transcription subunit 25
UniProt
Q71SY5
Pockets
2 · best druggability 0.36

Structure

solution nmr · 1 distinct chain · 28% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMediator of RNA polymerase II transcription subunit 25protein15928% helix, 36% strandQ71SY5

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1720.360.7719empty
2710.320.7413empty

Compared structures

  • 2XNF · The Mediator Med25 activator interaction domain: Structure and cooperative binding of… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q71SY5 · AlphaFold monomer V2.0 prediction for mediator of RNA polymerase II transcription subunit… · a predicted model of the same protein · chain A against A, TM-score 0.78

Analyse

Other records of 2XNF

  • 2XNF · MolNFT v2 / PDB Bank · The Mediator Med25 activator interaction domain: Structure and cooperative binding of…

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.